
AMWL
USDAmerican Well Corporation Class A Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$4.230
Максимум
$4.280
Минимум
$4.100
Объем
0.21M
Фундаментальные показатели компании
Рыночная капитализация
67.6M
Отрасль
Health Information Services
Страна
United States
Статистические данные торговли
Средний объем
0.08M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 2 нояб. 2025 г.AMWL Stock Analysis: American Well at Critical Support Level (November 2025)
Price Action Review
American Well (AMWL) has been in a downward spiral since August 2025, dropping from $7.01 to a 52-week low of $5.13 by October 30th. Key patterns observed:
- 87% crash from August high ($8.65) to October low ($5.13)
- Double-bottom formation at $5.13-$5.15 support zone (Oct 30-Nov 1)
- Volume spikes during decline (149k shares on Oct 10, 106k on Oct 22)
- Recent consolidation around $5.22 after hitting the 52-week low
Fundamental Snapshot
| Metric | Value | Commentary |
|---|---|---|
| Market Cap | $84.3M | Micro-cap stock (high risk) |
| P/E Ratio | -0.68x | "Better" than industry (-1.0x) |
| Return on Equity | -37.6% | Severe profitability issues |
| Debt-to-Equity | 2.17x | Exceeds healthy thresholds |
| Revenue Growth | 12.9% | Modest growth for healthcare tech |
Technical Indicators
- Bullish Breakout Signals
- Price hugging $5.15 support level
- MACD crossover (0.0056 > signal line 0.0001)
- On-Balance Volume surged to 4.7x average
- ADX at 9.2 suggests weak trend strength
- Critical Levels
- Support: $5.11 (recent low)
- Resistance: $5.31 (near take-profit level)
- Stop-loss: $4.69 (9% below entry)
Strategic Guidance
Buy Signal: $5.13-$5.19 range Take Profit: $5.31 (+3.5% target) Stop Loss: $4.69 (-8.5% risk) Hold Period: 1-2 weeks
Setup suggests a potential bounce from historic lows, though with limited upside projection. Traders should consider position sizing no more than 1-2% of portfolio given risk factors.
Risk Considerations
⚠️ Medium-High Risk Profile:
- Low Volatility: Makes breakout confirmation difficult
- Micro-Cap Status: Limited liquidity ($75k average volume)
- Fundamental Weakness: Negative ROE and high debt-to-equity ratio
- 52-week low trade: No margin for error at this support level
Current Outlook
While technicals show classic signs of short-term bottoming (volume surge + MACD crossover), fundamentals remain deeply problematic. The recommendation appears based primarily on bargain-hunting potential at extreme levels rather than business quality.
Given the AI prediction score of 0.0, traders should treat this as a pure technical play rather than fundamentals-driven growth opportunity. The neutral sentiment score and lack of news events suggest price action will be driven by technical factors and broader market conditions.
Action: Consider small-scale entry near $5.13 with strict risk management Timing: Setup valid for 19 more days (through Nov 21) Caution: Negative fundamentals make this a speculative trade
*This analysis is based solely on structured data dated 2025-11-02. Always verify current
Связанные новости
Amwell® Announces Results for Third Quarter 2025
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 10 нояб. 2025 г., 15:20
69.0% Уверенность
Риск и торговля
Точка входа
$4.15
Взять прибыль
$4.27
Остановить убытки
$3.77
Ключевые факторы
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.